Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Technetium × Clear all

Phase

Status

Sponsor Class

OTHER 8 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Lung Neoplasms 1

Interventions

pembrolizumab 1013 Carboplatin 951 Paclitaxel 925 Gemcitabine 782 Cisplatin 745 Docetaxel 677 Bevacizumab 606 Pemetrexed 497 Nivolumab 485 Cyclophosphamide 461 Capecitabine 457 Fluorouracil 410 Dexamethasone 395 Rituximab 370 Oxaliplatin 342 Injections 336 atezolizumab 298 Trastuzumab 296 Leucovorin 283 Cetuximab 277 Irinotecan 262 130-nm albumin-bound paclitaxel 251 Prednisone 244 Doxorubicin 239 Ipilimumab 223 Lenalidomide 218 Fulvestrant 211 fludarabine 207 durvalumab 204 Erlotinib Hydrochloride 188

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed

Lung Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡